A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age
Clinical trial NCT05630846 · COMPLETED
Trial details
- NCT number
- NCT05630846
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-14
- Primary completion
- 2024-06-07
- Enrollment
- 801
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.